Claris Lifesciences Limited DMF, CEP, Written Confirmations, FDF, Prices, Patents, Patents & Exclusivities, Dossier, Manufacturer, Licensing, Distributer, Suppliers, News, GMP

Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

Virtual Booth

Contact Supplier

Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

VISIT THE VIRTUAL BOOTH
Review portfolio & marketing content
CONTACT DETAILS
Google Map, LinkedIn, Emails...

DIGITAL CONTENT

25 News #PharmaBuzz

media
25 News #PharmaBuzz

FINISHED DOSAGE FORMULATIONS

23 FDF Dossiers, 23 Europe

23 FDF Dossiers
23 Europe

INSPECTIONS & REGISTRATIONS

4 FDA, 1 EDQM, 5 WHO-GMP, 1 GDUFA

inspections
4 FDA
1 EDQM
5 WHO-GMP
1 GDUFA

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Claris Lifesciences is an Indian sterile injectables pharmaceutical company with a market presence across 100 countries worldwide. We primarily manufacture and market products across multiple markets, and therapeutic segments. A significant majority of these products are generic drugs that are capable of being directly injected into the human body and are predominantly used in the treatment of critical illnesses. Our products range across various therapeutic segments, including anesthesia, critical care, renal care, enteral nutrition and oncology. We offer injectables in various delivery systems, such as glass bottles, vials, ampoules, and non-PVC/PVC bags. Our customer base primarily includes government and private hospitals, aid agencies, and nursing homes. We have three manufacturing facilities at a campus located in Ahmedabad, India. Certain of these facilities have been approved by foreign regulatory authorities including the USFDA, MHRA (UK), TGA (Australia), NAM (Finland), GCC FDCA (Gulf Co-operation Council including Saudi Arabia, U.A.E. and other countries in the Middle East), ANVISA (Brazil) and INVIMA (Colombia). Our manufacturing capabilities have received several awards from prestigious institutions like IDMA (Indian Drug Manufacturers' Association) and Frost & Sullivan. Our capabilities and experience span across all business verticals in the generic injectables industry. We have a trained workforce across business functions, such as R&D for product development, regulatory affairs for obtaining product registrations, manufacturing, and sales and marketing.